K042939 is an FDA 510(k) clearance for the CAPILLARY'S IMMUNOTYPING (PN 2100). This device is classified as a Kappa, Antigen, Antiserum, Control (Class II - Special Controls, product code DFH).
Submitted by Sebia, Inc. (Chelsea, US). The FDA issued a Cleared decision on June 27, 2005, 245 days after receiving the submission on October 25, 2004.
This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5550.
| 510(k) Number | K042939 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | October 25, 2004 |
| Decision Date | June 27, 2005 |
| Days to Decision | 245 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
| Product Code | DFH — Kappa, Antigen, Antiserum, Control |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.5550 |